NEUWAY Pharma
NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology based on a natural derived protein capsule.
In addition to advancing its proprietary pipeline, the company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue.
Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.
Meet us
Sept 08-10,2022, Pharmaceutics and Novel Drug Delivery Systems, Paris, France
Sep 21-22, 2022, OLIGONUCLEOTIDE THERAPEUTICS AND DELIVERY, London, GB
News
2022-02 EPR Article Drug Delivery feat. NEUWAY (Vol 27, Issue 1)
2021-06 nature journal: Crossing the barrier to treating brain diseases